TÜBİTAK 1501 Grant for R&D Project
We are proud to announce that we have been awarded a grant from TÜBİTAK’s 1501 Industrial R&D Projects 2023-2 Call.
Since its establishment in 2011, we continuously improve ourselves by specializing in creation of patented technologies and our products are based on the latest research, making them truly cutting-edge. Our goal is to bring revolutionary new ideas to the healthcare industry, and create value addition to our customers in global market, by our solutions and products ensuring that our clients receive products that meet the highest quality standards. With a team of talented and dedicated forces, we are committed to improving the lives of patients through our patient-centric solutions and services.
Data exchanges use the HL7 FHIR standard
Applications support Multi-Language
Offered as SaaS or PaaS according to needs
Components can operate independently
Screens are customizable based on client needs
We are proud to announce that we have been awarded a grant from TÜBİTAK’s 1501 Industrial R&D Projects 2023-2 Call.
As Oteo Technology, we had the privilege of presenting at the 5th April Cancer Week: Screening and Early Diagnosis Symposium organized by Istanbul University Oncology
Oteo participated in the Ministry of Health hosted an iftar gathering to bring together key stakeholders in the health technologies sector, fostering collaboration and dialogue
We’re excited to share that our company has received support through the 1507 – TÜBİTAK SME R&D Start-up Support Programme 2023-2 for our R&D project.